Noemí Puig - Publications, H-index & Citations

Noemí Puig

universidad de salamanca

44H指数

469论文数

8.1K被引数

收录论文 76

发表时间

Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing 利用下一代测序高灵敏度检测ctDNA，微创评估多发性骨髓瘤外周血可测量微小残留病

HemaSphere

IF14.6

2026-06-18

OAAI

Natalia Buenache; Marta Lasa; Andrés Arroyo; Carmen González; Larissa Haertle; Yanira Ruiz-Heredia; Rosa Ayala; Rafael Alonso; Alejandro Martín-Muñoz; Juan M. Rosa-Rosa; Verónica González; María J. Calasanz; Paula Rodríguez-Otero; Laura Rosiñol; Felipe De Arriba; Enrique M. Ocio; Albert Oriol; Yolanda González; Anna Sureda; Sunil Lakhwani; María E. Clavero; Angela Ibáñez; Clara Gómez; Alberto Orfao; María-Victoria Mateos; Juan J. Lahuerta; María T. Cedena; Joan Bladé; Jesús San Miguel; Noemi Puig; Bruno Paiva; Joaquín Martínez-López

Measurable residual disease in myeloma: a MyRiaD of findings 多发性骨髓瘤中的可测量残留疾病：MyRiaD研究结果

Blood

IF23.1

2026-06-04

PREAI

Noemi Puig

How Laboratory Innovations Are Shaping the Future of Multiple Myeloma Care 实验室创新如何塑造多发性骨髓瘤护理的未来

Cancers

IF4.4

2026-04-17

OAAI

Joana Caetano; Ana Marta Pires; Carlos Costa; Rui Bergantim; Adriana Roque; Patrícia Ferraz; Maria Rosário Cunha; Niccolo Bolli; Noemi Puig; Cristina João

Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study 定量MYD88 L265P和流式细胞术水平用于IgM异常免疫球蛋白病的预后判断：SAL-TO研究

Blood Advances

IF7.1

2026-03-25

OAAI

Irene Dogliotti; Cristina Jiménez; Veronica Peri; Martina Ferrante; Davide Musto; Silvio Mercadante; Gian Maria Zaccaria; Marco Ghislieri; Giulia Benevolo; Enrique María Ocio; Araceli Rubio; Ilda Murillo; Fernando Escalante; Carmen Aguilera; Mateo Aránzazu García; Alfonso García de Coca; Roberto Hernández; Julio Dávila; Federica Cavallo; Noemi Puig

A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometry 质谱时代下对IMWG多发性骨髓瘤完全缓解标准的批判性分析

HemaSphere

IF14.6

2026-02-18

OAAI

Noemí Puig; Cristina Agulló; Bruno Paiva; María-Teresa Cedena; Laura Rosiñol; Teresa Contreras; Joaquín Martínez-López; Albert Oriol; María-Jesús Blanchard; Rafael Ríos-Tamayo; Anna Sureda; Sunil Lakhwani; Javier de la Rubia; Valentín Cabañas; Felipe de Arriba; Miguel Paricio; María-Belén Iñigo; Verónica González-Calle; Enrique M. Ocio; Sergio Castro; Joan Bargay; Joan Bladé; Jesús F. San Miguel; Juan-José Lahuerta; María V. Mateos

Impact of the kinetics of circulating anti-BCMA CAR-T cells and normal lymphocytes on the outcome of MM patients 循环抗BCMA CAR-T细胞和正常淋巴细胞动力学对MM患者预后的影响

HemaSphere

IF14.6

2025-12-28

OAAI

Sara Gutiérrez-Herrero; Lourdes Martín-Martín; María Herrero-García; Borja Puertas; Eduarda da Silva Barbosa; María Victoria Mateos; Lucía López-Corral; Verónica González-Calle; Beatriz Rey-Búa; Ana África Martín-López; Estefanía Pérez-López; Fermín Sánchez-Guijo; Miriam López-Parra; Noemí Puig; Alberto Orfao; on behalf of the INCAR and Euroflow Consortium

Real-world evidence of measurable residual disease assessment in multiple myeloma 多发性骨髓瘤中可测量残留病灶评估的现实世界证据

Blood Advances

IF7.1

2025-12-15

OAAI

Maria-Teresa Cedena; Noemi Puig; Bruno Paiva; José-Enrique de la Puerta; Albert Pérez-Montaña; María Casanova; Joaquín Breña; Antoni García; Felipe de Arriba; Carmen Martínez-Chamorro; Maialen Sirvent; Maria-Jesús Blanchard; Rafael Alonso; Miguel-Ángel Álvarez; Francisco-Javier Capote; Ricarda García-Sánchez; José-Juan Pérez; Paula Rodriguez-Otero; Juan-José Lahuerta; Joaquín Martínez-López

Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish society of laboratory medicine and the Spanish society of hematology and hemotherapy. Part III: clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry Agulló, C.; Puig, N.; Varo, N.; Iglesias, M.Á.; Mugueta, C.; Pello, R.; Paiva, B.; Martínez-López, J.; Castro, S.; Cárdenas, M.C.; 等. 临床实验室中单克隆丙种球蛋白病的检测建议。西班牙临床实验室医学学会与西班牙血液学及血液治疗学会的共识。第三部分：利用MALDI-TOF质谱法检测单克隆丙种球蛋白病的临床与分析建议。Clin. Chem. Lab. Med. 2025. [Google Scholar] [CrossRef] [PubMed]

CLINICAL CHEMISTRY AND LABORATORY MEDICINE

IF3.7

2025-11-01

PREAI

Agullo, Cristina; Puig, Noemi; Varo, Nerea; Iglesias, Maria Angeles; Mugueta, Carmen; Pello, Rosa; Paiva, Bruno; Martinez-Lopez, Joaquin; Castro, Sergio; Cardenas, Maria Cruz; Garcia-Sanz, Ramon; Perez-Surribas, David; Flores-Montero, Juan; Ortiz-Espejo, Maria; De La Rubia, Javier; Cruz-Iglesias, Elena; Fontan, Adrian; Isidoro-Garcia, Maria; San-Miguel, Jesus; Mateos, Maria Victoria

Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance 低白蛋白血症：进展期单克隆丙种球蛋白病不典型患者的新风险因素

Blood Cancer Journal

IF11.6

2025-10-24

OAAI

Elena Alejo; Verónica González-Calle; Patricia Blázquez; Borja Puertas; Cristina Agulló; Beatriz Rey-Búa; Norma C. Gutiérrez; Noemi Puig; María-Victoria Mateos

Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician’s Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma Ciltacabtagene autoleucel在CARTITUDE-4研究中的比较有效性，与来自Flatiron登记研究中来那度胺难治性多发性骨髓瘤的真实世界医生选择疗法进行比较

Advances in Therapy

IF4

2025-08-06

OAAI

Cyrille Touzeau; Brea Lipe; Abdullah M. Khan; Binod Dhakal; Sandhya Nair; Jianming He; João Mendes; Seina Lee; Carolina Lonardi; Ana Slaughter; Nikoletta Lendvai; Jordan M. Schecter; Diana Chen; Man Zhao; Tzu-min Yeh; Xavier Leleu; Noemí Puig; Dominik Dytfeld; Elena Zamagni; Katja Weisel; Lionel Karlin; Michel Delforge; Paolo Corradini; Roberto Mina; Wilfried Roeloffzen; Surbhi Sidana

Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial bortezomib、melphalan和prednisone的诱导治疗，随后使用lenalidomide和dexamethasone，与carfilzomib、lenalidomide和dexamethasone（伴有或不伴有daratumumab）在老年、体能状态良好的新诊断多发性骨髓瘤患者中的比较（GEM-2017FIT）：一项III期、开放标签、多中心、随机临床试验

lancet haematology

IF0

2025-08-04

PREAI

María-Victoria Mateos; Bruno Paiva; M Teresa Cedena; Noemí Puig; Ana Maria Sureda-Balari; Verónica Gonzalez de la Calle; Albert Oriol; Enrique M Ocio; Laura Rosiñol; Yolanda González Montes; Joan Bargay; María Esther González García; Sunil Lakhwani; Angel Ramirez Payer; Alexia Suarez-Cabrera; María-Jesús Blanchard; Sebastián Garzón; Felipe Casado Montero; Valentín Cabañas; Jaime Pérez de Oteyza; Mercedes Gironella; Joaquín Martinez-Lopez; Ana Isabel Teruel Casasús; María Pilar Delgado-Beltrán; Elena Prieto; Juan José Lahuerta; Joan Bladé; Jesús San-Miguel

Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation 探索cyclin D1在多发性骨髓瘤发病机制中的作用，超越细胞周期调控

Molecular Oncology

IF4.5

2025-07-17

OAAI

Ignacio J. Cardona-Benavides; Sara Cristobal-Vargas; Cristina De Ramón; Elizabeta A. Rojas; Irena Misiewicz-Krzeminska; Isabel Isidro; José Juan Pérez; Bruno Paiva; Noemi Puig; Miguel Alcoceba; María-Victoria Mateos; Luis A. Corchete; Myriam Cuadrado; Norma C. Gutiérrez

High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial 高剂量白消安-美法仑 vs 美法仑及强化VRD方案用于新诊断多发性骨髓瘤：一项GEM III期试验

Blood

IF23.1

2025-06-14

PREAI

Juan José Lahuerta; Jesús San-Miguel; Ana Jiménez-Ubieto; Rafael Alonso; Bruno Paiva; Noemí Puig; M. Teresa Cedena; Norma Carmen Gutierrez; María José Calasanz; Manuela Fernández Guijarro; Rafael Ríos Tamayo; Albert Oriol Rocafiguera; María Jesús Blanchard; Estrella Carrillo Cruz; Rafael Martínez-Martínez; Joan Bargay; Ana Sureda Balari; Javier de la Rubia; Miguel Teodoro Hernández García; Valentín Cabañas; Felipe Casado Montero; Luis Palomera Bernal; Yolanda González Montes; Joaquín Martínez-Lopez; Paula Rodriguez-Otero; Isabel Krisnik; José M. Arguiñano; María Esther Gonzalez García; Enrique M. Ocio; Javier de la Cruz; María Victoria Mateos; Laura Rosiñol; Joan Bladé

Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison 比较cilta-cabtagene autoleucel与标准护理治疗用于既往接受过治疗的复发或难治性多发性骨髓瘤患者的疗效：一项匹配调整间接比较研究

ADVANCES IN THERAPY

IF4

2025-05-12

OAAI

Puig, N; Diels, J; van Sanden, S; Mendes, J; Burnett, H; Cichewicz, A; Lee, S; Hernando, T; Schecter, JM; Lendvai, N; Patel, N; Sanchez-Pina, JM; Rocchi, S; Mina, R; Corradini, P; Cavo, M; Miguel, JS; Shune, L; Khan, AM; Sidana, S; Leleu, X; Manier, S; Lipe, B; Weisel, K; Martinez-Lopez, J

Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre Experience 将达鲁单抗添加到免疫球蛋白轻链淀粉样变性患者一线治疗中的影响：一项单中心经验

CANCERS

IF4.4

2025-04-25

OAAI

Alejo, Elena; Agullo, Cristina; Puertas, Borja; Eiros, Rocio; Rey-Bua, Beatriz; Barnes, Carmen; Rodriguez-Gonzalez, Marta; Lopez-Corral, Lucia; Santos-Briz, Angel; Escalante, Fernando; Perez-Garcia, Maria-Luisa; Jimenez-Cabrera, Silvia; Gutierrez, Norma C.; Puig, Noemi; Mateos, Maria-Victoria; Gonzalez-Calle, Veronica

Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma 多发性骨髓瘤临床管理中MRD评估的机遇与挑战

NATURE REVIEWS CLINICAL ONCOLOGY

IF82.2

2025-04-07

PREAI

Paiva, Bruno; Shi, Qian; Puig, Noemi; Cedena, Maria-Teresa; Orfao, Alberto; Durie, Brian G. M.; Munshi, Nikhil C.; San-Miguel, Jesus

Expression profile of Bcl-2 family proteins in newly diagnosed multiple myeloma patients 初诊多发性骨髓瘤患者Bcl-2家族蛋白表达谱分析

HEMASPHERE

IF14.6

2024-12-13

OAAI

De Ramon, Cristina; Rojas, Elizabeta A.; Misiewicz-Krzeminska, Irena; Cardona-Benavides, Ignacio J.; Cuadrado, Myriam; Isidro, Isabel; Calasanz, Maria-Jose; Fernandez, Manuela; Garcia-Sanz, Ramon; Puig, Noemi; Cedena, M. Teresa; Paiva, Bruno; Rosinol, Laura; Martinez-Lopez, Joaquin; Blade, Joan; Lahuerta, Juan J.; San Miguel, Jesus F.; Mateos, Maria V.; Corchete, Luis A.; Gutierrez, Norma C.; GEM PETHEMA Cooperat Study Grp

Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy T细胞重定向免疫治疗复发/难治性多发性骨髓瘤患者完全缓解和可测量残留病的临床意义

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2024-11-16

OAAI

Zabaleta, Aintzane; Puig, Noemi; Cedena, Maria-Teresa; Oliver-Caldes, Aina; Perez, Jose J.; Moreno, Cristina; Tamariz-Amador, Luis-Esteban; Rodriguez-Otero, Paula; Prosper, Felipe; Gonzalez-Calle, Veronica; Lopez-Corral, Lucia; Rey-Bua, Beatriz; Puertas, Borja; Miras, Fatima; Sanchez-Pina, Jose Maria; Lopez-Munoz, Nieves; Juan, Manel; Gonzalez-Navarro, E. Azucena; Urbano, Alvaro; de Larrea, Carlos Fernandez; Blade, Joan; Lahuerta, Juan-Jose; Martinez-Lopez, Joaquin; Mateos, Maria-Victoria; San Miguel, Jesus F.; Paiva, Bruno

Long-Term Effects of Belantamab Mafodotin Plus Bortezomib, Lenalidomide and Dexamethasone (VRd) on T Cell Exhaustion Phenotype Belantamab Mafodotin 联合硼替佐米、来那度胺和地塞米松（VRd）对T细胞耗竭表型的长期影响

BLOOD

IF23.1

2024-11-05

PREAI

Lorenzo, Mauro; Garces, Juan-Jose; Burgos, Leire; Manrique, Irene; Lasa, Marta; Puig, Noemi; Sotolongo-Ravelo, Janet; Gonzalez-Rodriguez, Marta; Castellanos, Barbara; Romero, Maria Teresa Cedena; Paiva, Bruno; Gonzalez-Calle, Veronica; Mateos, Maria-Victoria; Garayoa, Mercedes; Paino, Teresa

Ultra-sensitive cfDNA analysis for minimally invasive measurable residual disease detection and profiling in multiple myeloma 超敏cfDNA分析用于多发性骨髓瘤中微创可测量微小残留病灶的检测与分型

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Buenache, N.; Martin-Munoz, A.; Ruiz-Heredia, Y.; Lasa, M.; Notarfranchi, L.; Gonzalez, C.; Cedena, M. T.; Barrio, S.; Calasanz, M. J.; Mateos, M-V.; Rosinol, L.; Lahuerta, J. J.; Blade, J.; Puig, N.; Paiva, B.; Martinez-Lopez, J.

研究方向